03/04/2025
Pharmaceutical products are set to avoid significant tariffs from key U.S. trade partners as President Donald Trump unveils reciprocal tariffs impacting over 60 nations.
Experts highlight India's pharmaceutical sector as a major beneficiary of this tariff approach. With India importing $800 million in pharmaceutical products from the US and exporting $8.7 billion worth of pharma goods to the American market, the country emerges as a significant winner in this trade strategy.
According to the American Society of Health-System Pharmacists (ASHP), the number of drug shortages in the US in the third quarter of 2024 was around 271.
Source :
Financialexpress
Pharmaceutical products are set to avoid significant tariffs from key U.S. trade partners as President Donald Trump unveils reciprocal tariffs impacting over 60 nations. Experts highlight India's pharmaceutical sector as a major beneficiary of this tariff approach. With India importing $800 mill...